Asimov is an AI-driven life sciences tools and services company that develops and deploys platforms for the design and production of biologics and genomic medicines. The company’s LV and AAV Edge stable cell line platforms achieve titers up to E9 TU/mL for lentivirus and 6E12 vg/mL for AAV. Asimov's RNA Edge platform optimizes expression profile with integrated modeling, genetic parts, and validation screening.


 Products

  • Intelligent Design of Living Systems: AAV, Lentivirus, RNA

    LV Edge: Stable packaging and producer cell lines with model-guided DNA design, achieving lentiviral titers up to E9 TU/mL for clinically relevant CARs while reducing GMP plasmid requirements.
    AAV Edge: Modular platform combining AI-designed payload optimization, including tissue-specific promoters, sequence optimization, and GOI silencing, with stable HEK293 producer cell lines achieving titers up to 6E12 vg/mL.
    RNA Edge: Model-guided RNA sequence design to optimize expression and stability for RNA therapeutics.

    ...